drugset / Trial / NCT01883596

Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.

NCT01883596

Phase 4 Unknown 70 enrolled Sinaloa Pediatric Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine the efficacy of prophylaxis with 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical care unit.

Timeline

Start
2012-10
Primary completion
2016-10
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule 0.12 % Topical

Indications

No indication recorded.